{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:03:53Z","timestamp":1759565033910},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.tips.2010.08.005","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T04:32:12Z","timestamp":1285043532000},"page":"523-527","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic approaches to spinal and bulbar muscular atrophy"],"prefix":"10.1016","volume":"31","author":[{"given":"Srikanth","family":"Ranganathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth H.","family":"Fischbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2010.08.005_bib0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1468-1331.2009.02591.x","article-title":"Bulbar and spinal muscular atrophy (Kennedy's disease): a review","volume":"16","author":"Finsterer","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tips.2010.08.005_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF03036451","article-title":"Progress in spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor","volume":"7","author":"Beitel","year":"2005","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.tips.2010.08.005_bib0015","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/brain\/awp258","article-title":"Clinical features of spinal and bulbar muscular atrophy","volume":"132","author":"Rhodes","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.tips.2010.08.005_bib0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0896-6273(04)00082-0","article-title":"Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration","volume":"41","author":"Sopher","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2010.08.005_bib0025","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","article-title":"Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"24","author":"Chevalier-Larsen","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2010.08.005_bib0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00401-007-0287-5","article-title":"CAG repeat disorder models and human neuropathology: similarities and differences","volume":"115","author":"Yamada","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2010.08.005_bib0035","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1172\/JCI28773","article-title":"Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model","volume":"116","author":"Yu","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2010.08.005_bib0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/hmg\/ddn419","article-title":"17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse","volume":"18","author":"Tokui","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2010.08.005_bib0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1547","article-title":"ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor","volume":"13","author":"Yang","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2010.08.005_bib0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsbmb.2007.09.016","article-title":"The role of the polyglutamine tract in androgen receptor","volume":"108","author":"Palazzolo","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tips.2010.08.005_bib0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2990.2007.00830.x","article-title":"Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy","volume":"33","author":"Adachi","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tips.2010.08.005_bib0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.expneurol.2006.01.021","article-title":"Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA)","volume":"200","author":"Katsuno","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2010.08.005_bib0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1083\/jcb.149.2.255","article-title":"Cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch","volume":"149","author":"Becker","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2010.08.005_bib0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/hmg\/8.5.731","article-title":"Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone","volume":"8","author":"Stenoien","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2010.08.005_bib0080","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1212\/WNL.59.5.770","article-title":"Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women","volume":"59","author":"Schmidt","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2010.08.005_bib0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ana.21540","article-title":"Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy","volume":"65","author":"Banno","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2010.08.005_bib0210","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","article-title":"Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"9","author":"Katsuno","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2010.08.005_bib0090","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/ijms10031000","article-title":"Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy","volume":"10","author":"Banno","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2010.08.005_bib0095","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1074\/jbc.M609972200","article-title":"Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2010.08.005_bib0100","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/sj.mt.6300163","article-title":"Hsp40 molecules that target to the ubiquitin\u2013proteasome system decrease inclusion formation in models of polyglutamine disease","volume":"15","author":"Howarth","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2010.08.005_bib0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00109-006-0066-0","article-title":"Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein","volume":"84","author":"Waza","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.tips.2010.08.005_bib0110","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1298","article-title":"17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration","volume":"11","author":"Waza","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2010.08.005_bib0115","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington's disease","volume":"448","author":"Bennett","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tips.2010.08.005_bib0120","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.1242-07.2007","article-title":"CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model","volume":"27","author":"Adachi","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2010.08.005_bib0125","doi-asserted-by":"crossref","first-page":"13986","DOI":"10.1073\/pnas.0906463106","article-title":"Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin\/proteasome system impairment","volume":"106","author":"Maynard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2010.08.005_bib0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11912-010-0086-3","article-title":"Hsp90: a drug target?","volume":"12","author":"Holzbeierlein","year":"2010","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.tips.2010.08.005_bib0135","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.3032-06.2006","article-title":"Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration","volume":"26","author":"Katsuno","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2010.08.005_bib0140","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nn1717","article-title":"JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport","volume":"9","author":"Morfini","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2010.08.005_bib0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","article-title":"Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy","volume":"63","author":"Palazzolo","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2010.08.005_bib0150","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/hmg\/ddm109","article-title":"Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity","volume":"16","author":"Palazzolo","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2010.08.005_bib0155","first-page":"263","article-title":"Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools","volume":"41","author":"Boutillier","year":"2007","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.tips.2010.08.005_bib0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/13543784.17.2.169","article-title":"Histone deacetylase inhibitors: possible implications for neurodegenerative disorders","volume":"17","author":"Hahnen","year":"2008","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.tips.2010.08.005_bib0165","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2010.08.005_bib0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cub.2009.11.022","article-title":"Chaperone-assisted selective autophagy is essential for muscle maintenance","volume":"20","author":"Arndt","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tips.2010.08.005_bib0175","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1093\/hmg\/ddq257","article-title":"The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS)","volume":"19","author":"Crippa","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2010.08.005_bib0180","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/hmg\/ddp115","article-title":"Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy","volume":"18","author":"Montie","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2010.08.005_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/hmg\/ddn310","article-title":"Mitochondrial abnormalities in spinal and bulbar muscular atrophy","volume":"18","author":"Ranganathan","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2010.08.005_bib0190","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","article-title":"Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial","volume":"6","author":"Di Prospero","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2010.08.005_bib0195","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.apmr.2010.04.007","article-title":"Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxia","volume":"91","author":"Drinkard","year":"2010","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.tips.2010.08.005_bib0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/10715760290021333","article-title":"Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia","volume":"36","author":"Rustin","year":"2002","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.tips.2010.08.005_bib0205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/01.wnl.0000341274.61236.02","article-title":"Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease)","volume":"72","author":"Preisler","year":"2009","journal-title":"Neurology"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614710001513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614710001513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T19:47:39Z","timestamp":1559677659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614710001513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0165614710001513"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2010.08.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}